Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report

Authors: Dinusha Chandratilleke, Anthea Anantharajah, Mauro Vicaretti, Warwick Benson, Lucinda J. Berglund

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Large vessel vasculitis is a rare disorder usually occurring in the context of the autoimmune conditions of giant cell arteritis and Takayasu’s arteritis. Case reports have described large vessel vasculitis occurring in individuals with myelodysplastic syndrome, preceding transformation to acute myeloid leukemia.

Case presentation

A 56-year-old Afghanistan-born woman presented with fever, a tender left carotid artery, and raised inflammatory markers. Computed tomography revealed thickening of the wall of her left carotid artery. Her symptoms resolved spontaneously; however, they recurred weeks later on the contralateral side, along with abdominal pain after eating. Further imaging with computed tomography and positron emission tomography demonstrated resolution of her left carotid artery abnormality, but new wall thickening and inflammation in her right carotid artery, abdominal aorta, and superior mesenteric artery. She was diagnosed as having large vessel vasculitis, which resolved with corticosteroids and methotrexate. Five months later, she developed acute myeloid leukemia. She had no known history of myelodysplastic syndrome at the time of diagnosis with vasculitis.

Conclusions

Large vessel vasculitis in older individuals presenting with atypical clinical features, such as a migratory pattern of affected vessels, vessel wall tenderness, and marked systemic inflammation, should prompt a search for underlying myelodysplasia. Clinicians should be vigilant for progression to acute myeloid leukemia.
Literature
2.
go back to reference Katsuyama T, Uchida HA, Toma K, Maeda Y, Hirota D, Umebayashi R, Sada KE, Makino H. Large vessel vasculitis with myelodysplastic syndrome. Intern Med. 2014;53:63–6.CrossRefPubMed Katsuyama T, Uchida HA, Toma K, Maeda Y, Hirota D, Umebayashi R, Sada KE, Makino H. Large vessel vasculitis with myelodysplastic syndrome. Intern Med. 2014;53:63–6.CrossRefPubMed
3.
go back to reference de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed
4.
go back to reference Freitas DS, Camargo CZ, Mariz HA, Arraes AE, de Souza AW. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. Rheumatol Int. 2012;32:703–9.CrossRefPubMed Freitas DS, Camargo CZ, Mariz HA, Arraes AE, de Souza AW. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. Rheumatol Int. 2012;32:703–9.CrossRefPubMed
5.
go back to reference Cohen MJ, Shyman A, Klein M, Ben-Yehuda A, Rubinow A, Or R, Goldschmidt N. Large vessel (Takayasu’s) arteritis in a patient with myelodysplastic syndrome: is there a common pathogenesis? Clin Lymphoma Myeloma Leuk. 2011;11:60–3.CrossRefPubMed Cohen MJ, Shyman A, Klein M, Ben-Yehuda A, Rubinow A, Or R, Goldschmidt N. Large vessel (Takayasu’s) arteritis in a patient with myelodysplastic syndrome: is there a common pathogenesis? Clin Lymphoma Myeloma Leuk. 2011;11:60–3.CrossRefPubMed
6.
go back to reference Steurer M, Fritsche G, Tzankov A, Gotwald T, Sturm W, Konwalinka G, Gruber J. Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol. 2004;73:128–33.CrossRefPubMed Steurer M, Fritsche G, Tzankov A, Gotwald T, Sturm W, Konwalinka G, Gruber J. Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol. 2004;73:128–33.CrossRefPubMed
7.
go back to reference Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41:866–71.CrossRefPubMed Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41:866–71.CrossRefPubMed
8.
go back to reference Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, Tamura A, Fujimori Y, Takemoto Y, Kanamaru A, Kakishita E. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol. 1997;66:345–51.CrossRefPubMed Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, Tamura A, Fujimori Y, Takemoto Y, Kanamaru A, Kakishita E. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol. 1997;66:345–51.CrossRefPubMed
9.
go back to reference Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood. 2002;100:3639–45.CrossRefPubMed Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood. 2002;100:3639–45.CrossRefPubMed
10.
go back to reference Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol. 1996;33:150–62.PubMed Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol. 1996;33:150–62.PubMed
11.
go back to reference Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford). 2004;43:626–32.CrossRef Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford). 2004;43:626–32.CrossRef
13.
go back to reference Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol. 1991;18:721–7.PubMed Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol. 1991;18:721–7.PubMed
14.
go back to reference de Hollanda A, Beucher A, Henrion D, Ghali A, Lavigne C, Levesque H, Hamidou M, Subra JF, Ifrah N, Belizna C. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken). 2011;63:1188–94.CrossRef de Hollanda A, Beucher A, Henrion D, Ghali A, Lavigne C, Levesque H, Hamidou M, Subra JF, Ifrah N, Belizna C. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken). 2011;63:1188–94.CrossRef
15.
go back to reference Fraison JB, Mekinian A, Grignano E, Kahn JE, Arlet JB, Decaux O, Denis G, Buchdahl AL, Omouri M, Maigne G, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–7.CrossRefPubMed Fraison JB, Mekinian A, Grignano E, Kahn JE, Arlet JB, Decaux O, Denis G, Buchdahl AL, Omouri M, Maigne G, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–7.CrossRefPubMed
Metadata
Title
Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report
Authors
Dinusha Chandratilleke
Anthea Anantharajah
Mauro Vicaretti
Warwick Benson
Lucinda J. Berglund
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1239-x

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue